Tower Research Capital (TRC)’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.75K Buy
+603
New +$1.75K ﹤0.01% 4751
2025
Q1
Sell
-929
Closed -$957 5751
2024
Q4
$957 Buy
929
+660
+245% +$680 ﹤0.01% 5125
2024
Q3
$360 Sell
269
-7
-3% -$9 ﹤0.01% 5362
2024
Q2
$359 Buy
276
+60
+28% +$78 ﹤0.01% 5348
2024
Q1
$372 Buy
216
+215
+21,500% +$370 ﹤0.01% 5514
2023
Q4
$1 Sell
1
-571
-100% -$571 ﹤0.01% 5895
2023
Q3
$692 Buy
572
+537
+1,534% +$650 ﹤0.01% 5498
2023
Q2
$51 Sell
35
-506
-94% -$737 ﹤0.01% 5844
2023
Q1
$1K Sell
541
-32,623
-98% -$60.3K ﹤0.01% 5610
2022
Q4
$57K Buy
33,164
+14,925
+82% +$25.7K ﹤0.01% 2259
2022
Q3
$37K Sell
18,239
-6,838
-27% -$13.9K ﹤0.01% 3437
2022
Q2
$19K Buy
25,077
+12,654
+102% +$9.59K ﹤0.01% 3858
2022
Q1
$108K Buy
12,423
+3,655
+42% +$31.8K ﹤0.01% 2146
2021
Q4
$141K Buy
8,768
+7,761
+771% +$125K ﹤0.01% 2013
2021
Q3
$19K Sell
1,007
-7,377
-88% -$139K ﹤0.01% 3777
2021
Q2
$117K Buy
8,384
+5,238
+166% +$73.1K ﹤0.01% 2304
2021
Q1
$46K Buy
3,146
+1,986
+171% +$29K ﹤0.01% 3197
2020
Q4
$22K Sell
1,160
-14,624
-93% -$277K ﹤0.01% 3815
2020
Q3
$176K Buy
15,784
+13,043
+476% +$145K ﹤0.01% 2693
2020
Q2
$37K Buy
+2,741
New +$37K ﹤0.01% 3284
2019
Q4
Sell
-223
Closed -$2K 4302
2019
Q3
$2K Sell
223
-495
-69% -$4.44K ﹤0.01% 3739
2019
Q2
$8K Buy
+718
New +$8K ﹤0.01% 2712
2019
Q1
Sell
-1,120
Closed -$7K 4246
2018
Q4
$7K Buy
1,120
+1,082
+2,847% +$6.76K ﹤0.01% 2711
2018
Q3
$0 Sell
38
-99
-72% ﹤0.01% 4212
2018
Q2
$2K Buy
+137
New +$2K ﹤0.01% 3369
2018
Q1
Sell
-2,089
Closed -$24K 3832
2017
Q4
$24K Buy
+2,089
New +$24K ﹤0.01% 1927